NTRANatera, Inc.
228.80USD-1.13%Mkt Cap: 32.77B $P/E:

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence mon…

Industry Peers

Diagnostics & Research
Screen all
vs Diagnostics & Research
P/B
Pricier
1M Perf
Lower
TMO
Thermo Fisher Scientific Inc.
$172.44BUSDP/E 25.5
+270.5% 1M
DHR
Danaher Corporation
$126.12BUSDP/E 34.5
+417.3% 1M
LONN
Lonza Group AG
$39.89BUSDP/E 38.4
+133.7% 1M
IDXX
IDEXX Laboratories, Inc.
$43.05BUSDP/E 40.1
-141.8% 1M
A
Agilent Technologies, Inc.
$35.72BUSDP/E 25.4
+1117.1% 1M
WAT
Waters Corporation
$35.18BUSDP/E 45.6
+496.0% 1M
IQV
IQVIA Holdings Inc.
$28.01BUSDP/E 20.8
-214.0% 1M
ILMN
Illumina, Inc.
$24.42BUSDP/E 29.3
+1371.2% 1M
MTD
Mettler-Toledo International Inc.
$23.52BUSDP/E 27.3
+751.8% 1M
DGX
Quest Diagnostics Incorporated
$21.43BUSDP/E 21.4
-8.8% 1M
LH
Labcorp Holdings Inc.
$20.86BUSDP/E 22.6
-116.1% 1M
GH
Guardant Health, Inc.
$17.08BUSD
+1205.5% 1M
MEDP
Medpace Holdings, Inc.
$13.01BUSDP/E 28.7
+801.0% 1M
ERF
Eurofins Scientific SE
$11.96BUSDP/E 24.9
+63.9% 1M
RVTY
Revvity, Inc.
$11.05BUSDP/E 47.6
+447.3% 1M
BIM
bioMérieux S.A.
$8.64BUSDP/E 20.2
-804.9% 1M
CRL
Charles River Laboratories International, Inc.
$8.75BUSD
+1636.2% 1M
TWST
Twist Bioscience Corporation
$5.30BUSD
+5872.2% 1M
BLLN
BillionToOne, Inc.
$4.63BUSDP/E 183.1
+2079.6% 1M
SHC
Sotera Health Company
$4.49BUSDP/E 38.4
+122.2% 1M
RDNT
RadNet, Inc.
$4.38BUSD
+285.9% 1M
VCYT
Veracyte, Inc.
$4.24BUSDP/E 49.2
+1770.3% 1M
DIA
DiaSorin S.p.A.
$3.54BUSDP/E 24.9
+133.1% 1M
ADPT
Adaptive Biotechnologies Corporation
$2.78BUSD
+2442.7% 1M
GRAL
GRAIL, Inc.
$2.67BUSD
-595.2% 1M
WGS
GeneDx Holdings Corp.
$1.65BUSD
+2389.9% 1M
VIMIAN
Vimian Group AB (publ)
$1.48BUSDP/E 38.0
-17.1% 1M
DIA
Diagnostyka S.A.
$1.48BUSDP/E 22.3
+707.2% 1M
NEO
NeoGenomics, Inc.
$1.46BUSD
+2584.3% 1M
CDNA
CareDx, Inc.
$1.29BUSD
+1844.0% 1M
OPK
OPKO Health, Inc.
$1.08BUSD
+1626.0% 1M
PSNL
Personalis, Inc.
$1.07BUSD
+2792.4% 1M
CBAV
Clínica Baviera, S.A.
$975.44MUSDP/E 20.4
+256.4% 1M
CSTL
Castle Biosciences, Inc.
$643.00MUSD
+584.1% 1M
LBIRD
Lumibird SA
$580.42MUSDP/E 37.8
-161.0% 1M
FLGT
Fulgent Genetics, Inc.
$506.67MUSD
+871.4% 1M
MYGN
Myriad Genetics, Inc.
$425.02MUSD
+1811.0% 1M
VOX
Voxel S.A.
$318.12MUSDP/E 3.2
+2589.5% 1M
EDT
Spectral Medical Inc.
$290.61MUSD
-422.5% 1M
BDSX
Biodesix, Inc.
$179.67MUSD
+2073.8% 1M
IMDX
Insight Molecular Diagnostics Inc.
$174.37MUSD
-1276.3% 1M
SLV
Selvita S.A.
$138.97MUSD
-132.0% 1M
XGN
Exagen Inc.
$106.79MUSD
+1540.5% 1M
ALECR
Eurofins-Cerep SA
$83.88MUSDP/E 16.1
-377.4% 1M
BIOPOR
BioPorto A/S
$83.29MUSD
-85.8% 1M
PANG
Pangaea Oncology, S.A.
$60.90MUSD
-63.7% 1M
PRPO
Precipio, Inc.
$41.55MUSD
-338.7% 1M
ABDX
Abingdon Health Plc
$30.70MUSD
-217.4% 1M
NN6
NanoRepro AG
$27.15MUSD
+2000.0% 1M
GDR
genedrive plc
$22.25MUSD
+1590.9% 1M
SENZA
SenzaGen AB
$16.98MUSD
+186.6% 1M
IMMNOV
Immunovia AB (publ)
$12.87MUSD
+341.3% 1M
BMX
BioMaxima S.A.
$10.17MUSDP/E 63.9
-1259.1% 1M
ALPRE
Predilife S.A.
$9.77MUSD
-1768.9% 1M
XWEL
XWELL, Inc.
$9.63MUSD
-2191.8% 1M
VRCI
Verici Dx plc
$9.02MUSD
-1176.5% 1M
OBD
Oxford BioDynamics Plc
$8.40MUSD
-526.3% 1M
BIAF
bioAffinity Technologies, Inc.
$7.08MUSD
-5120.5% 1M
NDRA
ENDRA Life Sciences Inc.
$6.58MUSD
-666.7% 1M
PRM
Proteome Sciences plc
$5.72MUSD
+0.0% 1M
AVCR
Avricore Health Inc.
$5.06MUSD
-1538.5% 1M
JUMP
Leveljump Healthcare Corp.
$3.86MUSDP/E 2.8
+0.0% 1M
ISPC
iSpecimen Inc.
$3.62MUSD
-2588.2% 1M
TELO
Telo Genomics Corp.
$3.29MUSD
-1666.7% 1M
PROGEN
Prostatype Genomics AB (publ)
$2.83MUSD
+3157.9% 1M
NOTV
Inotiv Inc
$2.79MUSD
-9442.3% 1M
PRPH
ProPhase Labs, Inc.
$1.09MUSD
-2909.1% 1M
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
+0.0% 1M
TTOO
T2 Biosystems, Inc.
$14.0KUSD
-8333.3% 1M
Indicators:|

Key Statistics

Company
Market Cap32.77B $
Enterprise Value32.29B $
Revenue (TTM)2.50B $
Gross Profit1.49B $
Net Income (TTM)-208.16M $
Revenue/Share18.07 USD
Last Price228.80 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6.1K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1110.52
PEG
EV/EBITDA-120.69
EV/Revenue12.91
P/S13.25
P/B18.62
EPS (TTM)-1.62
EPS (Forward)-0.21
52W Range
131.8178% of range256.36
52W High256.36 USD
52W Low131.81 USD
Profitability
Gross Margin64.75%
Oper. Margin-12.39%
EBITDA Margin-10.70%
Profit Margin-9.03%
ROE-12.16%
ROA-8.68%
Growth
Revenue Growth38.80%
Earnings Growth
Cash Flow & Leverage
Operating CF215.30M $
CapEx (TTM)139.19M $
FCF Margin5.47%
FCF Yield0.42%
Net Debt-847.85M $
Net Debt/EBITDA3.17
Balance Sheet
Debt/Equity0.13
Current Ratio2.96
Quick Ratio2.70
Book Value/Sh12.43 USD
Cash/Share7.596 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)260.05 USD
Upside (mean)+13.7%
Target Range193.00 USD300.00 USD
$193.00+13.7% to mean$300.00
# Analysts20
Ownership
Shares Out.143.22M
Float138.91M
Insiders3.02%
Institutions96.10%
Short Interest
Short Ratio2.1d
Short % Float2.60%
Short % Out.2.52%
Shares Short3.61M
Short (prev mo.)4.02M
Technical
SMA 50207.88 (+10.1%)
SMA 200206.57 (+10.8%)
Beta1.54
S&P 52W Chg24.49%
Avg Vol (30d)1.39M
Avg Vol (10d)1.26M
Technical Indicators
RSI (14)60.0
MACD5.5500
MACD Signal4.3270
MACD Hist.+1.2230
BB Upper232.89 USD
BB Middle216.58 USD
BB Lower200.27 USD
BB Width15.06%
ATR (14)10.99 USD
Vol Ratio (20d)1.20x